Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes.

Tsamos, Georgios; Vasdeki, Dimitra; Koufakis, Theocharis; Michou, Vassiliki; Makedou, Kali; Tzimagiorgis, Georgios

Tsamos, Georgios; Vasdeki, Dimitra; Koufakis, Theocharis; Michou, Vassiliki; Makedou, Kali; Tzimagiorgis, Georgios.

Afiliação

Tsamos G; Division of Gastroenterology, Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK.
Vasdeki D; Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.
Koufakis T; Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.
Michou V; Sports Medicine Laboratory, School of Physical Education & Sport Science, Aristotle University of Thessaloniki, 57001 Thessaloniki, Greece.
Makedou K; Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.
Tzimagiorgis G; Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece.

Metabolites ; 13(4)2023 Apr 04.

Article em En | MEDLINE | ID: mdl-37110175

Palavras-chave

diabetes mellitus; fatty liver disease; fibrosis; glucose-lowering drugs; lifestyle approaches; resolution of NAFLD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Metabolites Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google